Recalls & Warnings August 29, 2012 Herbal Supplement Company Warned For Medical Claims On August 2, 2012, the FDA issued a warning to HSAC Enterprises, Inc
Psychological Studies about Eating Behavior (3): A Japanese version of the Dutch Eating Behavior Questionnaire (DEBQ)
A 2025 study of 228,000 individuals with obesity, Type 2 diabetes, or alcohol use disorder, semaglutide and liraglutide use was associated with a 36% and 28% lower risk, respectively, of alcohol-related hospitalizations (such as intoxication and withdrawal symptoms) compared to patients who weren't prescribed GLP-1 medications (Lhteenvuo et al., 2025)
Claims of easy weight loss are a big red flag
For researchers who benefit from seeing these techniques in action, weve found that some of the content on YouTube can be incredibly helpful